KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) EBIT Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.16%
Dec 31, 2025 27.77%
Sep 30, 2025 -5.55%
Jun 30, 2025 -8.33%
Mar 31, 2025 56.47%
Dec 31, 2024 -12.09%
Sep 30, 2024 -23.77%
Jun 30, 2024 -58.83%
Mar 31, 2024 -148.74%
Dec 31, 2023 -59.12%
Sep 30, 2023 -22.07%
Jun 30, 2023 1.70%
Mar 31, 2023 0.91%
Dec 31, 2022 4.06%
Sep 30, 2022 18.32%
Jun 30, 2022 -22.70%
Mar 31, 2022 -25.68%
Dec 31, 2021 -9.25%
Sep 30, 2021 -20.38%
Jun 30, 2021 -33.23%
Mar 31, 2021 -20.26%
Dec 31, 2020 -57.88%
Sep 30, 2020 -17.37%
Jun 30, 2020 -2.21%
Mar 31, 2020 -53.78%
Dec 31, 2019 -20.63%
Sep 30, 2019 -238.28%
Jun 30, 2019 18.44%
Mar 31, 2019 55.59%
Dec 31, 2018 23.62%
Sep 30, 2018 28.13%
Jun 30, 2018 -13.90%
Mar 31, 2018 20.12%
Dec 31, 2017 -9.95%
Sep 30, 2017 29.33%
Jun 30, 2017 -8.06%
Mar 31, 2017 -0.96%
Dec 31, 2016 -27.80%
Sep 30, 2016 -9.70%
Jun 30, 2016 5.77%
Mar 31, 2016 7.30%
Dec 31, 2015 -323.48%
Sep 30, 2015 -18.43%
Jun 30, 2015 -38.25%
Mar 31, 2015 32.71%
Dec 31, 2014 -55.46%
Sep 30, 2014 -66.80%
Jun 30, 2014 -30.80%
Mar 31, 2014 -10.74%